Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer

This publication has 16 references indexed in Scilit:

• The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
  International Journal of Molecular Sciences, 2017
• Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies
  Annals of Oncology, 2014
• Therapeutic Targeting of a Robust Non-Oncogene Addiction to PRKDC in ATM -Defective Tumors
  Science Translational Medicine, 2013
• BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling
  Oncogene, 2013
• The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
  Annals of Oncology, 2013
• 53BP1 Regulates DSB Repair Using Rif1 to Control 5′ End Resection
  Science, 2013
• RNF8 Regulates Assembly of RAD51 at DNA Double-Strand Breaks in the Absence of BRCA1 and 53BP1
  Cancer Research, 2012
• Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations
  Clinical Cancer Research, 2011
• Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
  PLOS ONE, 2009
• PALB2 is an integral component of the BRCA complex required for homologous recombination repair
  Proceedings of the National Academy of Sciences, 2009